SCHEMBL9033128

SCHEMBL9033128

O=C(c1cccc(Cl)c1)c1ccnc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
PSMD14 O00487 1/20 0.50
MAPK1 P28482 1/20 0.50
CTDSP1 Q9GZU7 1/20 0.50
FADS1 O60427 1/20 0.48
MAOB P27338 1/20 0.46
CTSV O60911 1/20 0.45
CTSL P07711 1/20 0.45
CTSS P25774 1/20 0.45
ALOX15 P16050 1/20 0.45
ALDH1A1 P00352 2/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
TACR1 P25103 2/20 0.43
VNN1 O95497 1/20 0.43
KCNQ3 O43525 1/20 0.43
KCNQ2 O43526 1/20 0.43
KCNE1 P15382 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17151063 0.83 ALDH1A1 (0.48) ALDH1A1HPGDHTTNPSR1MEN1
SCHEMBL5591940 0.81 KDM4E (0.50) MAPK1ALDH1A1HTTNPSR1MEN1
SCHEMBL10112866 0.80 RECQL (0.47) NPC1RAB9AFADS1CTSVCTSL
SCHEMBL9033666 0.80 KDM4E (0.56) NPC1RAB9AALOX15ALDH1A1HPGD
SCHEMBL23193358 0.79 NCF1 (0.50) NPC1RAB9A
SCHEMBL5234876 0.78 CYP1A2 (0.49) NPC1RAB9APSMD14MAPK1CTDSP1
SCHEMBL9034890 0.78 ALOX15 (0.46) NPC1RAB9APSMD14MAPK1CTDSP1
SCHEMBL3446883 0.76 PARP1 (0.59) NPC1RAB9AMAOBALOX15ALDH1A1
SCHEMBL9032661 0.75 MEN1 (0.51) NPC1RAB9AALOX15ALDH1A1TACR3
SCHEMBL9033595 0.75 MCHR1 (0.48) NPC1RAB9APSMD14MAPK1CTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5589484-A TREATMENT OF HELICOBACTER INFECTIONS, ANTIULCER JANSSEN PHARMACEUTICA N.V. (BE) 1996-12-31 US disclosed
EP-0666855-B1 4-QUINOLINYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY JANSSEN PHARMACEUTICA NV (BE) 1996-09-18 EP disclosed
EP-0666855-A1 4-QUINOLINYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY. JANSSEN PHARMACEUTICA NV (BE) 1995-08-16 EP disclosed
WO-1994010164-A1 4-QUINOLINYL DERIVATIVES WITH ANTI-HELICOBACTER ACTIVITY JANSSEN PHARMACEUTICA N.V. (BE) 1994-05-11 WO disclosed